Viridian Therapeutics, Inc.\DE (VRDN) Other Gross PP&E Adjustments (2016 - 2025)
Viridian Therapeutics, Inc.\DE (VRDN) has 12 years of Other Gross PP&E Adjustments data on record, last reported at -$11.8 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 59.87% year-over-year to -$11.8 million; the TTM value through Dec 2025 reached -$11.8 million, down 59.87%, while the annual FY2025 figure was -$11.8 million, 59.87% down from the prior year.
- Other Gross PP&E Adjustments reached -$11.8 million in Q4 2025 per VRDN's latest filing, down from -$700000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $654000.0 in Q3 2021 and bottomed at -$14.0 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$2.8 million, with a median of -$1.7 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 592.97% in 2022, then skyrocketed 73.05% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$2.7 million in 2021, then increased by 7.96% to -$2.4 million in 2022, then crashed by 471.98% to -$14.0 million in 2023, then surged by 46.93% to -$7.4 million in 2024, then crashed by 59.87% to -$11.8 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$11.8 million in Q4 2025, -$700000.0 in Q3 2025, and -$2.0 million in Q2 2025.